<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Irinotecan pathway" Organism="Homo sapiens">
  <Comment Source="WikiPathways-category">Physiological Process</Comment>
  <Comment Source="WikiPathways-description">This pathway shows the biotransformation of the chemotherapy prodrug irinotecan to form the active metabolite SN-38, an inhibitor of DNA topoisomerase I. SN-38 is primarily metabolized to the inactive SN-38 glucuronide by UGT1A1, the isoform catalyzing bilirubin glucuronidation. Irinotecan is used in the treatment of metastatic colorectal cancer, small cell lung cancer and several other solid tumors. There is large interpatient variability in response to irinotecan, as well as severe side effects such as diarrhea and neutropenia, which might be explained in part by genetic variation in the metabolic enzymes and transporters depicted here. Well-known variants to effect this pathway are the promoter polymorphic repeat in UGT1A1 (UGT1A1*28) and the 1236C&gt;T polymorphism in ABCB1. While UGT1A1*28 genotype has been associated with toxicity, further evidence is needed to describe the roles of ABCB1 variants in toxicity.

Source: [http://www.pharmgkb.org/search/pathway/irinotecan/liver.jsp PharmGkb]

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP229 CPTAC Assay Portal]</Comment>
  <Graphics BoardWidth="771.0" BoardHeight="888.6666666666666"/>
  <DataNode TextLabel="SN-38G" GraphId="a1e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="UGT1A10" GraphId="a56" Type="GeneProduct" GroupRef="de3df">
        </DataNode>
  <DataNode TextLabel="ABCC2" GraphId="aa3" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Irinotecan" GraphId="b4030" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="NPC1" GraphId="b6274" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CES2" GraphId="b6c" Type="GeneProduct" GroupRef="ca03f">
        </DataNode>
  <DataNode TextLabel="CES1" GraphId="b81" Type="GeneProduct" GroupRef="beb36">
        </DataNode>
  <DataNode TextLabel="CYP3A4" GraphId="b9a" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="BCHE" GraphId="bcf" Type="GeneProduct" GroupRef="c56f2">
        </DataNode>
  <DataNode TextLabel="ABCC1" GraphId="be5" Type="GeneProduct" GroupRef="fc56e">
        </DataNode>
  <DataNode TextLabel="CES2" GraphId="bef" Type="GeneProduct" GroupRef="c56f2">
        </DataNode>
  <DataNode TextLabel="SN-38" GraphId="bfe" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="SN-38G" GraphId="c2f" Type="Metabolite">
    <Graphics Color="0033ff"/>
    </DataNode>
  <DataNode TextLabel="SN-38" GraphId="c3f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CES1" GraphId="c65" Type="GeneProduct" GroupRef="c56f2">
        </DataNode>
  <DataNode TextLabel="ABCC2" GraphId="c7f" Type="GeneProduct" GroupRef="b6f14">
        </DataNode>
  <DataNode TextLabel="ABCC1" GraphId="c8f" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="UGT1A9" GraphId="c92" Type="GeneProduct" GroupRef="be2d5">
        </DataNode>
  <DataNode TextLabel="CYP3A4" GraphId="cc6" Type="GeneProduct" GroupRef="e55dd">
        </DataNode>
  <DataNode TextLabel="APC" GraphId="cd3" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CES1" GraphId="cf6" Type="GeneProduct" GroupRef="ca03f">
        </DataNode>
  <DataNode TextLabel="UGT1A1" GraphId="cf7" Type="GeneProduct" GroupRef="de3df">
        </DataNode>
  <DataNode TextLabel="ABCC2" GraphId="d03" Type="GeneProduct" GroupRef="fc56e">
        </DataNode>
  <DataNode TextLabel="UGT1A1" GraphId="d1d" Type="GeneProduct" GroupRef="be2d5">
        </DataNode>
  <DataNode TextLabel="ABCC1" GraphId="d30" Type="GeneProduct" GroupRef="b6f14">
        </DataNode>
  <DataNode TextLabel="M4" GraphId="ded" Type="Metabolite">
    <Comment>molecular weight, 558</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP3A5" GraphId="e19" Type="GeneProduct" GroupRef="c7bbd">
        </DataNode>
  <DataNode TextLabel="SN-38" GraphId="e7a" Type="Metabolite">
    <Graphics Color="0033ff"/>
    </DataNode>
  <DataNode TextLabel="CES2" GraphId="e81" Type="GeneProduct" GroupRef="b5ca3">
        </DataNode>
  <DataNode TextLabel="ABCG2" GraphId="ec2" Type="GeneProduct" GroupRef="fc56e">
        </DataNode>
  <DataNode TextLabel="Irinotecan" GraphId="ef2" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP3A5" GraphId="ef5" Type="GeneProduct" GroupRef="e55dd">
        </DataNode>
  <DataNode TextLabel="CES1" GraphId="f50" Type="GeneProduct" GroupRef="b5ca3">
        </DataNode>
  <DataNode TextLabel="SLCO1B1" GraphId="f6030" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Irinotecan" GraphId="f808d" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CES2" GraphId="fb1" Type="GeneProduct" GroupRef="beb36">
        </DataNode>
  <DataNode TextLabel="CYP3A4" GraphId="fe8" Type="GeneProduct" GroupRef="c7bbd">
        </DataNode>
  <Interaction GraphId="a4c48">
    <BiopaxRef>fd7</BiopaxRef>
    <BiopaxRef>d54</BiopaxRef>
    <BiopaxRef>cc6</BiopaxRef>
    <BiopaxRef>d4c</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="e7a"/>
      <Point GraphRef="c2f" ArrowHead="Arrow"/>
      <Anchor Position="0.5135135135135135" Shape="None" GraphId="ce2fe"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a5b4c">
    <BiopaxRef>cb7</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="ef2"/>
      <Point GraphRef="bfe" ArrowHead="Arrow"/>
      <Anchor Position="0.3336964884097475" Shape="None" GraphId="a16ee"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a87c6">
    <Graphics Color="ff8080">
      <Point GraphRef="c3f"/>
      <Point GraphRef="d64" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aac68">
    <Graphics ConnectorType="Curved" Color="0080ff">
      <Point GraphRef="a1e"/>
      <Point/>
      <Point GraphRef="c3f" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ab64b">
    <Graphics>
      <Point GraphRef="ebd3a"/>
      <Point GraphRef="c708e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2ae0">
    <BiopaxRef>bc2</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="c3f"/>
      <Point GraphRef="a1e" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="dd9b6"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b414d">
    <Graphics Color="0080ff">
      <Point GraphRef="b6274"/>
      <Point GraphRef="e7a" ArrowHead="Arrow"/>
      <Anchor Position="0.5952882827030379" Shape="None" GraphId="e06a9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b587f">
    <Graphics>
      <Point GraphRef="afef5"/>
      <Point GraphRef="fc826" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6a36">
    <Graphics Color="0099ff">
      <Point GraphRef="c28da"/>
      <Point GraphRef="dd9b6"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b709c">
    <BiopaxRef>ae6</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="b4030"/>
      <Point GraphRef="c3f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="c708e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c1e2c">
    <BiopaxRef>aa1</BiopaxRef>
    <BiopaxRef>a33</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="f808d"/>
      <Point GraphRef="cd3" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6599166893885606" Shape="None" GraphId="dda8b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c3c0d">
    <Graphics>
      <Point GraphRef="aa3"/>
      <Point GraphRef="e5e80" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c4e2c">
    <BiopaxRef>aa1</BiopaxRef>
    <BiopaxRef>a33</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="f808d"/>
      <Point GraphRef="b6274" ArrowHead="Arrow"/>
      <Anchor Position="0.29848913747825784" Shape="None" GraphId="d1429"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="caf06">
    <Graphics>
      <Point GraphRef="a3628"/>
      <Point GraphRef="ce2fe" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cd671">
    <BiopaxRef>ecb</BiopaxRef>
    <Graphics ConnectorType="Curved" Color="0080ff">
      <Point GraphRef="e7a"/>
      <Point/>
      <Point/>
      <Point GraphRef="bfe" ArrowHead="Arrow"/>
      <Anchor Position="0.7844546624977009" Shape="None" GraphId="e34b2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d5590">
    <Graphics Color="0080ff">
      <Point GraphRef="c2f"/>
      <Point GraphRef="a1e" ArrowHead="Arrow"/>
      <Anchor Position="0.322213305807367" Shape="None" GraphId="e5e80"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d5fe6">
    <Graphics Color="ff8080">
      <Point GraphRef="bfe"/>
      <Point GraphRef="fad" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d6434">
    <BiopaxRef>ac8</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="bfe"/>
      <Point GraphRef="e7a" ArrowHead="Arrow"/>
      <Anchor Position="0.17811358261629243" Shape="None" GraphId="b4fd1"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d6a1f">
    <BiopaxRef>e72</BiopaxRef>
    <Graphics ConnectorType="Curved" Color="0080ff">
      <Point GraphRef="e7a"/>
      <Point/>
      <Point GraphRef="c3f" ArrowHead="Arrow"/>
      <Anchor Position="0.6476648895658796" Shape="None" GraphId="d686a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df6a5">
    <Graphics>
      <Point GraphRef="c8f"/>
      <Point GraphRef="e34b2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9631">
    <BiopaxRef>e81</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="f808d"/>
      <Point GraphRef="b4030" ArrowHead="Arrow"/>
      <Anchor Position="0.633906342165943" Shape="None" GraphId="b89e3"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea697">
    <Graphics Color="0080ff">
      <Point GraphRef="ef2"/>
      <Point GraphRef="f808d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee2f1">
    <Graphics>
      <Point GraphRef="ca8b0"/>
      <Point GraphRef="b89e3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f3996">
    <Graphics>
      <Point GraphRef="a97ed"/>
      <Point GraphRef="d686a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f4540">
    <BiopaxRef>ae6</BiopaxRef>
    <Graphics ConnectorType="Curved" Color="0080ff">
      <Point GraphRef="f808d"/>
      <Point/>
      <Point GraphRef="e7a" ArrowHead="Arrow"/>
      <Anchor Position="0.5023319160624667" Shape="None" GraphId="fc826"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="febf4">
    <BiopaxRef>aa1</BiopaxRef>
    <BiopaxRef>a33</BiopaxRef>
    <Graphics Color="0080ff">
      <Point GraphRef="f808d"/>
      <Point GraphRef="ded" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4129984162781447" Shape="None" GraphId="ec38f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3177d278">
    <Graphics>
      <Point GraphRef="d7fa2"/>
      <Point GraphRef="a16ee" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id3e0947ec">
    <Graphics>
      <Point GraphRef="f6030"/>
      <Point GraphRef="b4fd1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id58ffe001">
    <Graphics>
      <Point GraphRef="d1057"/>
      <Point GraphRef="ec38f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id791c7646">
    <Graphics>
      <Point GraphRef="ee5f0"/>
      <Point GraphRef="d1429" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id86d54c24">
    <Graphics>
      <Point GraphRef="b9a"/>
      <Point GraphRef="dda8b" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idae8e4255">
    <Graphics>
      <Point GraphRef="d6b18"/>
      <Point GraphRef="e06a9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="dfc34">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b6274"/>
      <Point GraphRef="f96b9" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Model human liver cell showing blood, bile and intestinal compartments, indicating tissue&#10;involvment of genes in the irinotecan pathway." GraphId="d2c">
    <Graphics FillColor="ffffff" FontStyle="Italic"/>
  </Label>
  <Label TextLabel="Diarrhea" GraphId="d64">
    <Graphics FillColor="ffffff" Color="0000ff"/>
  </Label>
  <Label TextLabel="Intestine" GraphId="f0f">
    <Graphics FillColor="ffffff" Color="999999"/>
  </Label>
  <Label TextLabel="Neutropenia" GraphId="fad">
    <Graphics FillColor="ffffff" Color="0000ff"/>
  </Label>
  <Label TextLabel="Liver Cell" GraphId="ffe">
    <Graphics FillColor="ffffff" Color="999999"/>
  </Label>
  <Label TextLabel="NPC1" GraphId="f96b9" Href="https://omim.org/entry/257220">
    <Comment>NIEMANN-PICK DISEASE, TYPE C1</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Shape GraphId="b9d36">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="f2732">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Group GroupId="be2d5" GraphId="a3628" Style="Group"/>
  <Group GroupId="fc56e" GraphId="a97ed"/>
  <Group GroupId="ca03f" GraphId="afef5"/>
  <Group GroupId="de3df" GraphId="c28da" Style="Group"/>
  <Group GroupId="b6f14" GraphId="ca8b0"/>
  <Group GroupId="e55dd" GraphId="d1057" Style="Group"/>
  <Group GroupId="beb36" GraphId="d6b18" Style="Group"/>
  <Group GroupId="c56f2" GraphId="d7fa2" Style="Group"/>
  <Group GroupId="b5ca3" GraphId="ebd3a"/>
  <Group GroupId="c7bbd" GraphId="ee5f0" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc2">
      <bp:ID >12893990</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.</bp:TITLE>
      <bp:SOURCE >Pharmacogenetics</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Desai AA</bp:AUTHORS>
      <bp:AUTHORS >Innocenti F</bp:AUTHORS>
      <bp:AUTHORS >Ratain MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e81">
      <bp:ID >14646693</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.</bp:TITLE>
      <bp:SOURCE >Pharmacogenetics</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Sai K</bp:AUTHORS>
      <bp:AUTHORS >Kaniwa N</bp:AUTHORS>
      <bp:AUTHORS >Itoda M</bp:AUTHORS>
      <bp:AUTHORS >Saito Y</bp:AUTHORS>
      <bp:AUTHORS >Hasegawa R</bp:AUTHORS>
      <bp:AUTHORS >Komamura K</bp:AUTHORS>
      <bp:AUTHORS >Ueno K</bp:AUTHORS>
      <bp:AUTHORS >Kamakura S</bp:AUTHORS>
      <bp:AUTHORS >Kitakaze M</bp:AUTHORS>
      <bp:AUTHORS >Shirao K</bp:AUTHORS>
      <bp:AUTHORS >Minami H</bp:AUTHORS>
      <bp:AUTHORS >Ohtsu A</bp:AUTHORS>
      <bp:AUTHORS >Yoshida T</bp:AUTHORS>
      <bp:AUTHORS >Saijo N</bp:AUTHORS>
      <bp:AUTHORS >Kitamura Y</bp:AUTHORS>
      <bp:AUTHORS >Kamatani N</bp:AUTHORS>
      <bp:AUTHORS >Ozawa S</bp:AUTHORS>
      <bp:AUTHORS >Sawada J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >irinotecan drug pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001224</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd7">
      <bp:ID >11990381</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.</bp:TITLE>
      <bp:SOURCE >Pharmacogenomics J</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Iyer L</bp:AUTHORS>
      <bp:AUTHORS >Das S</bp:AUTHORS>
      <bp:AUTHORS >Janisch L</bp:AUTHORS>
      <bp:AUTHORS >Wen M</bp:AUTHORS>
      <bp:AUTHORS >Ram&#195;&#173;&#194;&#173;rez J</bp:AUTHORS>
      <bp:AUTHORS >Karrison T</bp:AUTHORS>
      <bp:AUTHORS >Fleming GF</bp:AUTHORS>
      <bp:AUTHORS >Vokes EE</bp:AUTHORS>
      <bp:AUTHORS >Schilsky RL</bp:AUTHORS>
      <bp:AUTHORS >Ratain MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hepatocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000182</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc6">
      <bp:ID >12730278</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.</bp:TITLE>
      <bp:SOURCE >J Pharmacol Exp Ther</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Jinno H</bp:AUTHORS>
      <bp:AUTHORS >Saeki M</bp:AUTHORS>
      <bp:AUTHORS >Saito Y</bp:AUTHORS>
      <bp:AUTHORS >Tanaka-Kagawa T</bp:AUTHORS>
      <bp:AUTHORS >Hanioka N</bp:AUTHORS>
      <bp:AUTHORS >Sai K</bp:AUTHORS>
      <bp:AUTHORS >Kaniwa N</bp:AUTHORS>
      <bp:AUTHORS >Ando M</bp:AUTHORS>
      <bp:AUTHORS >Shirao K</bp:AUTHORS>
      <bp:AUTHORS >Minami H</bp:AUTHORS>
      <bp:AUTHORS >Ohtsu A</bp:AUTHORS>
      <bp:AUTHORS >Yoshida T</bp:AUTHORS>
      <bp:AUTHORS >Saijo N</bp:AUTHORS>
      <bp:AUTHORS >Ozawa S</bp:AUTHORS>
      <bp:AUTHORS >Sawada J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb7">
      <bp:ID >10197614</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Morton CL</bp:AUTHORS>
      <bp:AUTHORS >Wadkins RM</bp:AUTHORS>
      <bp:AUTHORS >Danks MK</bp:AUTHORS>
      <bp:AUTHORS >Potter PM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d4c">
      <bp:ID >9466980</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Iyer L</bp:AUTHORS>
      <bp:AUTHORS >King CD</bp:AUTHORS>
      <bp:AUTHORS >Whitington PF</bp:AUTHORS>
      <bp:AUTHORS >Green MD</bp:AUTHORS>
      <bp:AUTHORS >Roy SK</bp:AUTHORS>
      <bp:AUTHORS >Tephly TR</bp:AUTHORS>
      <bp:AUTHORS >Coffman BL</bp:AUTHORS>
      <bp:AUTHORS >Ratain MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >diarrhea</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:13250</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >cancer</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:162</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d54">
      <bp:ID >12181437</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Gagn&#195;&#169; JF</bp:AUTHORS>
      <bp:AUTHORS >Montminy V</bp:AUTHORS>
      <bp:AUTHORS >Belanger P</bp:AUTHORS>
      <bp:AUTHORS >Journault K</bp:AUTHORS>
      <bp:AUTHORS >Gaucher G</bp:AUTHORS>
      <bp:AUTHORS >Guillemette C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a33">
      <bp:ID >11602529</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Sai K</bp:AUTHORS>
      <bp:AUTHORS >Kaniwa N</bp:AUTHORS>
      <bp:AUTHORS >Ozawa S</bp:AUTHORS>
      <bp:AUTHORS >Sawada JI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >enterocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000584</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aa1">
      <bp:ID >10815927</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.</bp:TITLE>
      <bp:SOURCE >Clin Cancer Res</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Santos A</bp:AUTHORS>
      <bp:AUTHORS >Zanetta S</bp:AUTHORS>
      <bp:AUTHORS >Cresteil T</bp:AUTHORS>
      <bp:AUTHORS >Deroussent A</bp:AUTHORS>
      <bp:AUTHORS >Pein F</bp:AUTHORS>
      <bp:AUTHORS >Raymond E</bp:AUTHORS>
      <bp:AUTHORS >Vernillet L</bp:AUTHORS>
      <bp:AUTHORS >Risse ML</bp:AUTHORS>
      <bp:AUTHORS >Boige V</bp:AUTHORS>
      <bp:AUTHORS >Gouyette A</bp:AUTHORS>
      <bp:AUTHORS >Vassal G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ecb">
      <bp:ID >10220571</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Chen ZS</bp:AUTHORS>
      <bp:AUTHORS >Furukawa T</bp:AUTHORS>
      <bp:AUTHORS >Sumizawa T</bp:AUTHORS>
      <bp:AUTHORS >Ono K</bp:AUTHORS>
      <bp:AUTHORS >Ueda K</bp:AUTHORS>
      <bp:AUTHORS >Seto K</bp:AUTHORS>
      <bp:AUTHORS >Akiyama SI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e72">
      <bp:ID >12810652</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Rajendra R</bp:AUTHORS>
      <bp:AUTHORS >Gounder MK</bp:AUTHORS>
      <bp:AUTHORS >Saleem A</bp:AUTHORS>
      <bp:AUTHORS >Schellens JH</bp:AUTHORS>
      <bp:AUTHORS >Ross DD</bp:AUTHORS>
      <bp:AUTHORS >Bates SE</bp:AUTHORS>
      <bp:AUTHORS >Sinko P</bp:AUTHORS>
      <bp:AUTHORS >Rubin EH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae6">
      <bp:ID >12960109</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Irinotecan pathway genotype analysis to predict pharmacokinetics.</bp:TITLE>
      <bp:SOURCE >Clin Cancer Res</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Mathijssen RH</bp:AUTHORS>
      <bp:AUTHORS >Marsh S</bp:AUTHORS>
      <bp:AUTHORS >Karlsson MO</bp:AUTHORS>
      <bp:AUTHORS >Xie R</bp:AUTHORS>
      <bp:AUTHORS >Baker SD</bp:AUTHORS>
      <bp:AUTHORS >Verweij J</bp:AUTHORS>
      <bp:AUTHORS >Sparreboom A</bp:AUTHORS>
      <bp:AUTHORS >McLeod HL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >neutropenia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:1227</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac8">
      <bp:ID >15608127</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Nozawa T</bp:AUTHORS>
      <bp:AUTHORS >Minami H</bp:AUTHORS>
      <bp:AUTHORS >Sugiura S</bp:AUTHORS>
      <bp:AUTHORS >Tsuji A</bp:AUTHORS>
      <bp:AUTHORS >Tamai I</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>Niemann-Pick disease type C1</bp:TERM><bp:ID>DOID:0070113</bp:ID><bp:Ontology>Disease</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>